Nova Biomedical develops, manufactures, and sells advanced technology blood testing analyzers. We employ over 1,000 people, with sales and service subsidiaries in eight countries and distributors in more than 90 additional countries. Nova has manufacturing facilities in Waltham and Billerica, Massachusetts, and in Taipei, Taiwan. Nova is one of the 25 largest in vitro diagnostic companies in the world and the largest privately owned in vitro diagnostic company in the United States.
Nova has sales and service operations in 100 countries through Nova subsidiaries or distributors. Nova’s wholly-owned subsidiaries are located in Brazil, Canada, France, Germany, the U.K., Japan, and the U.S., with distributors in 92 additional countries. Nova subsidiaries and distributors provide product information, demonstrations, local product inventory, and complete technical support. Whether you are located in North America, Europe, Russia, Eastern Europe, the Middle East, Africa, Asia, the Pacific Islands, Latin America, or the Indian Subcontinent, Nova can support your point-of-care and critical care testing needs. Nova’s global manufacturing operations take place in four facilities certified by the International Organization for Standardization (ISO) and are located in Waltham and Billerica, Massachusetts, USA; Taipei, Taiwan; and Belo Horizonte, Brazil. These facilities occupy a total of 42,000 square meters (420,000 square feet) of manufacturing space.
